AOD‑9604 – 5mg

AOD‑9604 is a synthetic research peptide corresponding to the 176–191 fragment of human growth hormone (HGH). This fragment has been investigated in laboratory settings for its role in metabolic pathway studies, particularly those relating to lipid regulation and energy utilisation.

Unlike full‑length HGH, AOD‑9604 does not exhibit growth‑promoting activity, making it a distinct tool for researchers examining non‑growth‑related biochemical mechanisms.

Areas of Research Interest
Lipid Regulation Pathways
AOD‑9604 is frequently used in studies exploring biochemical processes involved in lipid breakdown and storage.

Energy Utilisation Models
Researchers employ this peptide in metabolic models to observe how specific peptide fragments may influence energy‑related signalling pathways.

Cartilage & Tissue Studies
Some preclinical investigations have examined AOD‑9604 in the context of tissue‑related research, including cartilage‑focused biochemical environments.

Non‑Growth Activity Profiling
A key area of interest is the peptide’s lack of interaction with IGF‑1 pathways, making it suitable for studies requiring non‑mitogenic peptide behaviour.

Technical Information
Chemical Name: AOD‑9604 (Fragment 176–191 of Human Growth Hormone)

Synonyms: HGH Fragment 176‑191, AOD9604

Molecular Formula: C₇₈H₁₂₃N₂₃O₂₃S₂

Molecular Weight: ~1815 g/mol

Sequence: Tyr‑Leu‑Arg‑Ile‑Val‑Gln‑Cys‑Arg‑Ser‑Val‑Gly‑Ser‑Cys‑Gly‑Phe

CAS Number: 221231‑10‑3

Classification: Synthetic peptide fragment derived from human growth hormone

Storage Guidelines
Lyophilised peptide is stable at room temperature for short periods.

For long‑term storage, keep at –20°C or below.

After reconstitution, store at 2–8°C.

Stability depends on the solvent used and laboratory handling conditions.

Solubility
Soluble in sterile water, acetic acid, or other aqueous buffers commonly used in peptide preparation.

References (Research Context Only)
Heffernan et al. (2001). AOD9604 fragment studies in metabolic models.

Ng et al. (2000). Synthetic peptide fragment investigations in lipid‑related research.

Ng et al. (2003). Preclinical safety assessments of AOD‑9604.

(Full citations available upon request. Direct links removed for compliance.)

Compliance Notice
For laboratory research use only. Not for human or animal administration.